Johnson Financial Group Inc (Wisconsin)’s Royalty Pharma RPRX Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68K	Hold	30	–	–	﹤0.01%	781
2026 Q1	$1.44K	Sell	30 -43	-59%	-$1.88K	﹤0.01%	831
2025 Q4	$2.82K	Buy	73 +43	+143%	+$1.64K	﹤0.01%	768
2025 Q3	$1.06K	Buy	+30	New	+$1.09K	﹤0.01%	1007
2024 Q4	–	Sell	-550	Closed	-$15.6K	–	966
2024 Q3	$15.6K	Buy	+550	New	+$15.2K	﹤0.01%	625
2024 Q2	–	Sell	-350	Closed	-$10.6K	–	940
2024 Q1	$10.6K	Buy	+350	New	+$10.3K	﹤0.01%	553

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s RPRX Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its Royalty Pharma (RPRX) position steady in Q2 2026 at 30 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #781.

Johnson Financial Group Inc (Wisconsin) first reported a position in RPRX in Q1 2024 and has held it in 6 quarters since. The position peaked at $15.6K in Q3 2024. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Johnson Financial Group Inc (Wisconsin) held 30 shares of Royalty Pharma worth $1.68K as of Q2 2026.
Johnson Financial Group Inc (Wisconsin) left its Royalty Pharma share count unchanged in Q2 2026.
Royalty Pharma made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #781 holding.
Johnson Financial Group Inc (Wisconsin) first reported a position in Royalty Pharma in Q1 2024 and has held it in 6 quarters since.
Johnson Financial Group Inc (Wisconsin)'s Royalty Pharma position peaked at $15.6K in Q3 2024.
641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.